About this trial
The goal of this clinical trial\] is to study the effectiveness of Virtual Reality (VR) in reducing pain and anxiety during painful procedures for patients with hematological malignancies The main question\[s\] it aims to answer are:
Does VR effectively reduce pain during painful procedures for patients with hematological malignancies ? Does VR effectively reduce anxiety during painful procedures for patients with hematological malignancies ? Interventional group (intra-group comparaison): This design allows each patient to act as his own control.: The intervention consists of a complete sequence involving three phases: Period 1 (standard care), a washout period of at least seven days, and Period 2 (VR session).
External control group (inter-group comparaison): Patients will be assigned to the intervention group first, and then a matching external control patient will be selected based on age and type of procedure.
Eligibility criteria
Qualifiers
being ≥ 6 years old
having a confirmed diagnosis of a hematological malignancy
undergoing at least one of the following procedures: Bone Marrow Biopsy, Bone Marrow Aspiration, Lumbar Puncture, Venipuncture, or Chemotherapy.
Disqualifiers
unstable or photosensitive epilepsy
hearing, visual, or inner ear impairments
severe psychiatric, cognitive, or mental disorders
Contagious diseases
Trial design
Treatments tested in this trial
- VR session
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.